がん領域における個別化医療の世界市場成長(現状と展望)2024-2030年Global Personalized Medicines In Oncology Market Growth (Status and Outlook) 2024-2030 LPI(LPインフォメーション)の最新調査によると、がん領域の個別化医療の世界市場規模は2023年に100万米ドルとなった。下流市場での需要の増加に伴い、個別化腫瘍学治療薬の市場規模は2030年までに100万米ドルに... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(LPインフォメーション)の最新調査によると、がん領域の個別化医療の世界市場規模は2023年に100万米ドルとなった。下流市場での需要の増加に伴い、個別化腫瘍学治療薬の市場規模は2030年までに100万米ドルに再調整され、レビュー期間中のCAGRは%になると予測されています。この調査レポートは、世界の個別化腫瘍薬市場の成長可能性を明らかにしています。がん領域の個別化医薬品は、今後の市場でも安定した成長が見込まれる。しかし、製品の差別化、コスト削減、サプライチェーンの最適化は、個別化治療薬の普及に不可欠であることに変わりはない。市場参入企業は、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供など、個別化がん治療薬市場がもたらす絶大な機会を活用する必要がある。 腫瘍学とは、血液がん、皮膚がん、乳がん、肺がんなど、さまざまな種類のがんの診断、治療、予防を指す医学の一種である。 当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間は年平均成長率5%で成長する。世界の医療支出は世界GDPの10%を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加の一途をたどっている。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。同市場は、世界的な高度医療サービスに対する需要の増加、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断と治療に対する意識の高まりなど、いくつかの要因によって牽引されている。 主な特徴 本レポートは、がん領域における個別化医療市場について様々な側面から考察し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、がん領域の個別化医薬品市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(分子腫瘍病理学、ゲノム診断学など)、地域別内訳などが含まれます。 市場促進要因と課題:本レポートでは、政府の規制、環境問題、技術の進歩、消費者の嗜好の変化など、がん領域の個別化医療市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制約、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができる。 競合情勢:この調査レポートは、がん領域の個別化医療市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。 技術開発:この調査レポートは、個別化腫瘍薬業界における最新の技術開発を掘り下げることができます。これには、個別化腫瘍薬技術の進歩、個別化腫瘍薬の新規参入、個別化腫瘍薬の新規投資、個別化腫瘍薬の将来を形作るその他の技術革新が含まれる。 川下の事業者の好み:本レポートは、個別化腫瘍薬市場における顧客の購買行動と採用動向を明らかにすることができます。このレポートには、顧客の購買意思決定に影響を与える要因や、個別化抗がん剤製品の嗜好が含まれています。 政府の政策とインセンティブこの調査レポートは、政府の政策とインセンティブが個別化腫瘍薬市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、その他個別化腫瘍薬市場の促進を目的とした施策の評価が含まれる。また、市場成長促進におけるこれらの政策の有効性についても評価する。 環境への影響と持続可能性この調査レポートは、個別化腫瘍薬市場の環境への影響と持続可能性の側面を評価しています。 市場予測と将来展望:調査レポートでは、実施した分析に基づいて、個別化腫瘍薬業界の市場予測と展望を提供している。これには、市場規模、成長率、地域別動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、がん領域の個別化医療市場の成長と発展に貢献するための潜在的な機会を明らかにしています。 市場の細分化 がん領域の個別化医療市場は、タイプ別と用途別に分類される。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。 タイプ別セグメント 分子腫瘍病理学 ゲノム診断 放射線療法 腫瘍学検査 化学療法 その他 用途別セグメント 研究センター 政府機関 病院 臨床センター その他 本レポートはまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 バイオタラノスティクス イルミナ DNAリンク Genomic Health, Inc. Cypher Genomics(ヒューマン・ロンジェヴィティ社) ライフテクノロジーズコーポレーション(サーモフィッシャーサイエンティフィック) フルージェント・ジェネティクス カリスライフサイエンス アリアナ製薬 アボットラボラトリーズ deCODEジェネティクス エクザジェン 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Personalized Medicines In Oncology Market Size 2019-2030 2.1.2 Personalized Medicines In Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Personalized Medicines In Oncology Segment by Type 2.2.1 Molecular Oncopathology 2.2.2 Genome Diagnostics 2.2.3 Radiation Therapy 2.2.4 Oncology Testing 2.2.5 Chemotherapy 2.2.6 Others 2.3 Personalized Medicines In Oncology Market Size by Type 2.3.1 Personalized Medicines In Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024) 2.4 Personalized Medicines In Oncology Segment by Application 2.4.1 Research Centers 2.4.2 Governmental Institutions 2.4.3 Hospitals 2.4.4 Clinical Centers 2.4.5 Others 2.5 Personalized Medicines In Oncology Market Size by Application 2.5.1 Personalized Medicines In Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024) 3 Personalized Medicines In Oncology Market Size by Player 3.1 Personalized Medicines In Oncology Market Size Market Share by Players 3.1.1 Global Personalized Medicines In Oncology Revenue by Players (2019-2024) 3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2019-2024) 3.2 Global Personalized Medicines In Oncology Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Personalized Medicines In Oncology by Regions 4.1 Personalized Medicines In Oncology Market Size by Regions (2019-2024) 4.2 Americas Personalized Medicines In Oncology Market Size Growth (2019-2024) 4.3 APAC Personalized Medicines In Oncology Market Size Growth (2019-2024) 4.4 Europe Personalized Medicines In Oncology Market Size Growth (2019-2024) 4.5 Middle East & Africa Personalized Medicines In Oncology Market Size Growth (2019-2024) 5 Americas 5.1 Americas Personalized Medicines In Oncology Market Size by Country (2019-2024) 5.2 Americas Personalized Medicines In Oncology Market Size by Type (2019-2024) 5.3 Americas Personalized Medicines In Oncology Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Personalized Medicines In Oncology Market Size by Region (2019-2024) 6.2 APAC Personalized Medicines In Oncology Market Size by Type (2019-2024) 6.3 APAC Personalized Medicines In Oncology Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Personalized Medicines In Oncology by Country (2019-2024) 7.2 Europe Personalized Medicines In Oncology Market Size by Type (2019-2024) 7.3 Europe Personalized Medicines In Oncology Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Personalized Medicines In Oncology by Region (2019-2024) 8.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2019-2024) 8.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Personalized Medicines In Oncology Market Forecast 10.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030) 10.1.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030) 10.1.2 Americas Personalized Medicines In Oncology Forecast 10.1.3 APAC Personalized Medicines In Oncology Forecast 10.1.4 Europe Personalized Medicines In Oncology Forecast 10.1.5 Middle East & Africa Personalized Medicines In Oncology Forecast 10.2 Americas Personalized Medicines In Oncology Forecast by Country (2025-2030) 10.2.1 United States Personalized Medicines In Oncology Market Forecast 10.2.2 Canada Personalized Medicines In Oncology Market Forecast 10.2.3 Mexico Personalized Medicines In Oncology Market Forecast 10.2.4 Brazil Personalized Medicines In Oncology Market Forecast 10.3 APAC Personalized Medicines In Oncology Forecast by Region (2025-2030) 10.3.1 China Personalized Medicines In Oncology Market Forecast 10.3.2 Japan Personalized Medicines In Oncology Market Forecast 10.3.3 Korea Personalized Medicines In Oncology Market Forecast 10.3.4 Southeast Asia Personalized Medicines In Oncology Market Forecast 10.3.5 India Personalized Medicines In Oncology Market Forecast 10.3.6 Australia Personalized Medicines In Oncology Market Forecast 10.4 Europe Personalized Medicines In Oncology Forecast by Country (2025-2030) 10.4.1 Germany Personalized Medicines In Oncology Market Forecast 10.4.2 France Personalized Medicines In Oncology Market Forecast 10.4.3 UK Personalized Medicines In Oncology Market Forecast 10.4.4 Italy Personalized Medicines In Oncology Market Forecast 10.4.5 Russia Personalized Medicines In Oncology Market Forecast 10.5 Middle East & Africa Personalized Medicines In Oncology Forecast by Region (2025-2030) 10.5.1 Egypt Personalized Medicines In Oncology Market Forecast 10.5.2 South Africa Personalized Medicines In Oncology Market Forecast 10.5.3 Israel Personalized Medicines In Oncology Market Forecast 10.5.4 Turkey Personalized Medicines In Oncology Market Forecast 10.5.5 GCC Countries Personalized Medicines In Oncology Market Forecast 10.6 Global Personalized Medicines In Oncology Forecast by Type (2025-2030) 10.7 Global Personalized Medicines In Oncology Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Biotheranostics 11.1.1 Biotheranostics Company Information 11.1.2 Biotheranostics Personalized Medicines In Oncology Product Offered 11.1.3 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Biotheranostics Main Business Overview 11.1.5 Biotheranostics Latest Developments 11.2 Illumina 11.2.1 Illumina Company Information 11.2.2 Illumina Personalized Medicines In Oncology Product Offered 11.2.3 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Illumina Main Business Overview 11.2.5 Illumina Latest Developments 11.3 DNA Link 11.3.1 DNA Link Company Information 11.3.2 DNA Link Personalized Medicines In Oncology Product Offered 11.3.3 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 DNA Link Main Business Overview 11.3.5 DNA Link Latest Developments 11.4 Genomic Health, Inc.(Exact Sciences) 11.4.1 Genomic Health, Inc.(Exact Sciences) Company Information 11.4.2 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered 11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Genomic Health, Inc.(Exact Sciences) Main Business Overview 11.4.5 Genomic Health, Inc.(Exact Sciences) Latest Developments 11.5 Cypher Genomics(Human Longevity, Inc.) 11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Information 11.5.2 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered 11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Cypher Genomics(Human Longevity, Inc.) Main Business Overview 11.5.5 Cypher Genomics(Human Longevity, Inc.) Latest Developments 11.6 Life Technologies Corporation(Thermo Fisher Scientific) 11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Information 11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered 11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Main Business Overview 11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments 11.7 Fulgent Genetics 11.7.1 Fulgent Genetics Company Information 11.7.2 Fulgent Genetics Personalized Medicines In Oncology Product Offered 11.7.3 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Fulgent Genetics Main Business Overview 11.7.5 Fulgent Genetics Latest Developments 11.8 Caris Life Sciences 11.8.1 Caris Life Sciences Company Information 11.8.2 Caris Life Sciences Personalized Medicines In Oncology Product Offered 11.8.3 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Caris Life Sciences Main Business Overview 11.8.5 Caris Life Sciences Latest Developments 11.9 Ariana Pharma 11.9.1 Ariana Pharma Company Information 11.9.2 Ariana Pharma Personalized Medicines In Oncology Product Offered 11.9.3 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Ariana Pharma Main Business Overview 11.9.5 Ariana Pharma Latest Developments 11.10 Abbott Laboratories 11.10.1 Abbott Laboratories Company Information 11.10.2 Abbott Laboratories Personalized Medicines In Oncology Product Offered 11.10.3 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Abbott Laboratories Main Business Overview 11.10.5 Abbott Laboratories Latest Developments 11.11 deCODE genetics 11.11.1 deCODE genetics Company Information 11.11.2 deCODE genetics Personalized Medicines In Oncology Product Offered 11.11.3 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 deCODE genetics Main Business Overview 11.11.5 deCODE genetics Latest Developments 11.12 Exagen Inc 11.12.1 Exagen Inc Company Information 11.12.2 Exagen Inc Personalized Medicines In Oncology Product Offered 11.12.3 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 Exagen Inc Main Business Overview 11.12.5 Exagen Inc Latest Developments 12 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Personalized Medicines In Oncology market size was valued at US$ million in 2023. With growing demand in downstream market, the Personalized Medicines In Oncology is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Personalized Medicines In Oncology Market Size 2019-2030 2.1.2 Personalized Medicines In Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Personalized Medicines In Oncology Segment by Type 2.2.1 Molecular Oncopathology 2.2.2 Genome Diagnostics 2.2.3 Radiation Therapy 2.2.4 Oncology Testing 2.2.5 Chemotherapy 2.2.6 Others 2.3 Personalized Medicines In Oncology Market Size by Type 2.3.1 Personalized Medicines In Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024) 2.4 Personalized Medicines In Oncology Segment by Application 2.4.1 Research Centers 2.4.2 Governmental Institutions 2.4.3 Hospitals 2.4.4 Clinical Centers 2.4.5 Others 2.5 Personalized Medicines In Oncology Market Size by Application 2.5.1 Personalized Medicines In Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024) 3 Personalized Medicines In Oncology Market Size by Player 3.1 Personalized Medicines In Oncology Market Size Market Share by Players 3.1.1 Global Personalized Medicines In Oncology Revenue by Players (2019-2024) 3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2019-2024) 3.2 Global Personalized Medicines In Oncology Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Personalized Medicines In Oncology by Regions 4.1 Personalized Medicines In Oncology Market Size by Regions (2019-2024) 4.2 Americas Personalized Medicines In Oncology Market Size Growth (2019-2024) 4.3 APAC Personalized Medicines In Oncology Market Size Growth (2019-2024) 4.4 Europe Personalized Medicines In Oncology Market Size Growth (2019-2024) 4.5 Middle East & Africa Personalized Medicines In Oncology Market Size Growth (2019-2024) 5 Americas 5.1 Americas Personalized Medicines In Oncology Market Size by Country (2019-2024) 5.2 Americas Personalized Medicines In Oncology Market Size by Type (2019-2024) 5.3 Americas Personalized Medicines In Oncology Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Personalized Medicines In Oncology Market Size by Region (2019-2024) 6.2 APAC Personalized Medicines In Oncology Market Size by Type (2019-2024) 6.3 APAC Personalized Medicines In Oncology Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Personalized Medicines In Oncology by Country (2019-2024) 7.2 Europe Personalized Medicines In Oncology Market Size by Type (2019-2024) 7.3 Europe Personalized Medicines In Oncology Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Personalized Medicines In Oncology by Region (2019-2024) 8.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2019-2024) 8.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Personalized Medicines In Oncology Market Forecast 10.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030) 10.1.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030) 10.1.2 Americas Personalized Medicines In Oncology Forecast 10.1.3 APAC Personalized Medicines In Oncology Forecast 10.1.4 Europe Personalized Medicines In Oncology Forecast 10.1.5 Middle East & Africa Personalized Medicines In Oncology Forecast 10.2 Americas Personalized Medicines In Oncology Forecast by Country (2025-2030) 10.2.1 United States Personalized Medicines In Oncology Market Forecast 10.2.2 Canada Personalized Medicines In Oncology Market Forecast 10.2.3 Mexico Personalized Medicines In Oncology Market Forecast 10.2.4 Brazil Personalized Medicines In Oncology Market Forecast 10.3 APAC Personalized Medicines In Oncology Forecast by Region (2025-2030) 10.3.1 China Personalized Medicines In Oncology Market Forecast 10.3.2 Japan Personalized Medicines In Oncology Market Forecast 10.3.3 Korea Personalized Medicines In Oncology Market Forecast 10.3.4 Southeast Asia Personalized Medicines In Oncology Market Forecast 10.3.5 India Personalized Medicines In Oncology Market Forecast 10.3.6 Australia Personalized Medicines In Oncology Market Forecast 10.4 Europe Personalized Medicines In Oncology Forecast by Country (2025-2030) 10.4.1 Germany Personalized Medicines In Oncology Market Forecast 10.4.2 France Personalized Medicines In Oncology Market Forecast 10.4.3 UK Personalized Medicines In Oncology Market Forecast 10.4.4 Italy Personalized Medicines In Oncology Market Forecast 10.4.5 Russia Personalized Medicines In Oncology Market Forecast 10.5 Middle East & Africa Personalized Medicines In Oncology Forecast by Region (2025-2030) 10.5.1 Egypt Personalized Medicines In Oncology Market Forecast 10.5.2 South Africa Personalized Medicines In Oncology Market Forecast 10.5.3 Israel Personalized Medicines In Oncology Market Forecast 10.5.4 Turkey Personalized Medicines In Oncology Market Forecast 10.5.5 GCC Countries Personalized Medicines In Oncology Market Forecast 10.6 Global Personalized Medicines In Oncology Forecast by Type (2025-2030) 10.7 Global Personalized Medicines In Oncology Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Biotheranostics 11.1.1 Biotheranostics Company Information 11.1.2 Biotheranostics Personalized Medicines In Oncology Product Offered 11.1.3 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Biotheranostics Main Business Overview 11.1.5 Biotheranostics Latest Developments 11.2 Illumina 11.2.1 Illumina Company Information 11.2.2 Illumina Personalized Medicines In Oncology Product Offered 11.2.3 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Illumina Main Business Overview 11.2.5 Illumina Latest Developments 11.3 DNA Link 11.3.1 DNA Link Company Information 11.3.2 DNA Link Personalized Medicines In Oncology Product Offered 11.3.3 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 DNA Link Main Business Overview 11.3.5 DNA Link Latest Developments 11.4 Genomic Health, Inc.(Exact Sciences) 11.4.1 Genomic Health, Inc.(Exact Sciences) Company Information 11.4.2 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered 11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Genomic Health, Inc.(Exact Sciences) Main Business Overview 11.4.5 Genomic Health, Inc.(Exact Sciences) Latest Developments 11.5 Cypher Genomics(Human Longevity, Inc.) 11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Information 11.5.2 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered 11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Cypher Genomics(Human Longevity, Inc.) Main Business Overview 11.5.5 Cypher Genomics(Human Longevity, Inc.) Latest Developments 11.6 Life Technologies Corporation(Thermo Fisher Scientific) 11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Information 11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered 11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Main Business Overview 11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments 11.7 Fulgent Genetics 11.7.1 Fulgent Genetics Company Information 11.7.2 Fulgent Genetics Personalized Medicines In Oncology Product Offered 11.7.3 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Fulgent Genetics Main Business Overview 11.7.5 Fulgent Genetics Latest Developments 11.8 Caris Life Sciences 11.8.1 Caris Life Sciences Company Information 11.8.2 Caris Life Sciences Personalized Medicines In Oncology Product Offered 11.8.3 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Caris Life Sciences Main Business Overview 11.8.5 Caris Life Sciences Latest Developments 11.9 Ariana Pharma 11.9.1 Ariana Pharma Company Information 11.9.2 Ariana Pharma Personalized Medicines In Oncology Product Offered 11.9.3 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Ariana Pharma Main Business Overview 11.9.5 Ariana Pharma Latest Developments 11.10 Abbott Laboratories 11.10.1 Abbott Laboratories Company Information 11.10.2 Abbott Laboratories Personalized Medicines In Oncology Product Offered 11.10.3 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Abbott Laboratories Main Business Overview 11.10.5 Abbott Laboratories Latest Developments 11.11 deCODE genetics 11.11.1 deCODE genetics Company Information 11.11.2 deCODE genetics Personalized Medicines In Oncology Product Offered 11.11.3 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 deCODE genetics Main Business Overview 11.11.5 deCODE genetics Latest Developments 11.12 Exagen Inc 11.12.1 Exagen Inc Company Information 11.12.2 Exagen Inc Personalized Medicines In Oncology Product Offered 11.12.3 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 Exagen Inc Main Business Overview 11.12.5 Exagen Inc Latest Developments 12 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD(oncology)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|